NSE - SMEListed
Nephro Care India Limited
Company websiteNephro Care India Limited targets ₹45,84,000 crore, split as fresh issue ₹45,84,000 crore and OFS ₹0 crore.
The offer represents 1600 shares. Apply from 28-06-2024 to 02-07-2024. Allotment on 03-07-2024, listing expected on 05-07-2024. Remember: subscription demand will influence listing-day price movements.
Start Date28-06-2024
End Date02-07-2024
Listing Date05-07-2024
Allotment Date03-07-2024
Current Price₹171
GMP₹175 (194.44%)
Lot Size1600 Shares
Subscription770.15 Times
Face Value₹10 Per Equity Share
Listing atNSE
Issue Price₹85 - ₹90
Pre Issue₹1,19,02,400
Post Issue₹1,64,86,400
Issue Size₹45,84,000
(aggregating up to 41.26 Cr)
(aggregating up to 41.26 Cr)
Fresh Issue₹45,84,000
(aggregating up to 41.26 Cr)
(aggregating up to 41.26 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Nephro Care India Limited is currently around ₹175 (194.44%). This indicates an estimated listing price of approximately ₹260 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
26 Nov 2025, 08:37 | ₹90 | ₹175 | ₹265 (194.44%) |
14 Nov 2025, 09:43 | ₹90 | ₹175 | ₹265 (194.44%) |
06 Mar 2025, 12:52 | ₹90 | ₹175 | ₹265 (194.44%) |
Financials overview in ₹ Lakhs
Here is a quick look at the recent financial performance of Nephro Care India Limited . The numbers below ( in ₹ Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Dec-23 | Mar-23 | Mar-22 |
|---|---|---|---|
EPS | 3.36 | 1.94 | -0.03 |
ROE | 41.57 | 132.46 | -3.84 |
ROCE | 36.56 | 71.09 | 4.13 |
RONW | 24.42 | 79.68 | -1.98 |
PRE IPO(PE) | 55.15 | 0 | 0 |
POST IPO(PE) | 32.73 | 0 | 0 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹7.43 | 1821.48 | 245.15 |
RETAIL | ₹13 | 8245.6 | 634.28 |
Total | ₹20.43 | 10067.08 | 492.76 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
Total | 0 | 0 | 0.00 |
The IPO reservation for Nephro Care India Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Retail | 46.31% | 14,44,800 |
NII(HNI) | 19.85% | 6,19,200 |
QIB | 26.46% | 8,25,600 |
Market Maker | 7.39% | 2,30,400 |
TOTAL | 100.00% | 31,20,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 1,600 | ₹1,44,000 | |
HNI | 2 | 3,200 | ₹2,88,000 |
Below you can find the official contact details of Nephro Care India Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@nephrocareindia.com/
Phone: +91 8017010197
Website: https://www.nephrocareindia.com/
Address: Flat No-1JC-18, 5th Floor Sec-III, Salt lake Kolkata, Bidhan Nagar Sai Complex, North 24 Parganas -700098